Acquired drug resistance during inadequate therapy in a young child with tuberculosis

Pediatric Infectious Disease Journal

Volumn 33, Issue 8, 2014, Pages 883-885

  Garcia Prats, Anthony J ^a   Willemse, Marianne ^b   Seifart, Heiner I ^c   Jordaan, Annemie M ^a   Werely, Cedric J ^a   Donald, Peter R ^a   Schaaf, H Simon ^a,d  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b Brooklyn Hospital for Chest Diseases   (South Africa)

^c Division of Pharmacology   (South Africa)

^d STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Acquired antibiotic resistance; Children; Isoniazid monoresistance; Multidrug resistance; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

CASE REPORT; DRUG EFFECTS; HUMAN; MALE; MICROBIOLOGY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PRESCHOOL CHILD; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

ANTITUBERCULAR AGENTS; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MALE; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 84905820489     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000336     Document Type: Article

References (10)

1. Mitchison DA. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. Int J Tuberc Lung Dis. 1998;2:10-15.
2. Schaaf HS, Van Rie A, Gie RP, et al. Transmission of multidrug-resistant tuberculosis. Pediatr Infect Dis J. 2000;19:695-699.
3. Schaaf HS, Parkin DP, Seifart HI, et al. Isoniazid pharmacokinetics in children treated for respiratory tuberculosis. Arch Dis Child. 2005;90:614-618.
4. Schaaf HS, Marais BJ, Whitelaw A, et al. Culture-confirmed childhood tuberculosis in Cape Town, South Africa: a review of 596 cases. BMC Infect Dis. 2007;7:140.
5. Srivastava S, Pasipanodya JG, Meek C, et al. Multidrug-resistant tuberculosis not due to noncompliance but to between-patient pharmacokinetic variability. J Infect Dis. 2011;204:1951-1959.
6. Donald PR, Sirgel FA, Venter A, et al. The influence of human N-acetyltransferase genotype on the early bactericidal activity of isoniazid. Clin Infect Dis. 2004;39:1425-1430.
7. Schaaf HS, Willemse M, Cilliers K, et al. Rifampin pharmacokinetics in children, with and without human immunodeficiency virus infection, hospitalized for the management of severe forms of tuberculosis. BMC Med. 2009;7:19.
8. Cynamon MH, Zhang Y, Harpster T, et al. High-dose isoniazid therapy for isoniazid-resistant murine Mycobacterium tuberculosis infection. Antimicrob Agents Chemother. 1999;43:2922-2924.
9. Seddon JA, Hesseling AC, Marais BJ, et al. The evolving epidemic of drugresistant tuberculosis among children in Cape Town, South Africa. Int J Tuberc Lung Dis. 2012;16:928-933.
10. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis: Emergency Update 2008. 2008. Available at: http://whqlibdoc.who.int/publications/2008/9789241547581-eng.pdf. Accessed March 22, 2012.